Investors

Motif Bio is a clinical stage biopharmaceutical company which specializes in developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Iclaprim is being developed for the treatment of the most common and serious bacterial infections... Read More

Stock Quote

MTFB (ADS)$8.99 Stock is Up 0.59 (7.02%)
Volume2,222
Today's Open$8.70
Previous Close$8.40
Data as of May 26, 2017 9:37 a.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.Learn More

Presentations

Upcoming Events

Motif Biosciences Inc Annual General Meeting
Thursday, June 15, 2017 2:00 p.m. UKT
Learn More